4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-036633
Chairman and CEO bought 17,200 shares at an average $1.58 ($27,142)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-05-26 | Purchase | +2,000 | $1.54 | $3,080 | 10,739,150 | D |
| Niihara Yutaka Chairman and CEO | 2021-05-27 | Purchase | +2,300 | $1.60 | $3,680 | 10,741,450 | D |
| Niihara Yutaka Chairman and CEO | 2021-05-28 | Purchase | +12,900 | $1.58 | $20,382 | 10,754,350 | D |
| Open-market purchases · 17,200 sh · avg $1.58 · $27,142 | |||||||
Loading xslF345X03/doc4.xml…